Loading compound...
Small molecule inhibitor
Alvocidib hydrochloride is a small molecule being studied for its potential to treat various types of blood cancers, including certain types of leukemia and lymphoma.
How it worksAlvocidib hydrochloride is a small molecule that has been studied for its ability to inhibit specific biological targets involved in cancer cell activity.
Used for
Prolymphocytic leukemiaFollicular lymphomaChronic lymphocytic leukemiaMALT lymphomaDiffuse large B-cell lymphomaMultiple myelomaWaldstrom macroglobulinemiaMantle cell lymphoma
Conditions
Prolymphocytic leukemiaFollicular lymphomaChronic lymphocytic leukemiaMALT lymphomaDiffuse large B-cell lymphomaMultiple myelomaWaldenstrom macroglobulinemiaMantle cell lymphoma
Class
Small moleculeSmall molecule inhibitorHematologic
How to take
This drug is currently in clinical development (Phase 2) and is not yet an approved treatment for these conditions according to the provided data.
Talk to your doctor
Questions to ask
- ·Is Alvocidib hydrochloride part of any clinical trials I might qualify for?
- ·How does Alvocidib hydrochloride work differently than my current treatment?
Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.
